9 results match your criteria: "USL Toscana Centro-Prato Hospital[Affiliation]"
Case Rep Oncol Med
December 2024
Oncology Unit Fondazione, IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
This case series highlights the complexity of sarcoidosis-like reactions (SLRs) during cancer treatment, specifically in patients receiving immunotherapy or targeted therapies for melanoma. SLRs can either mimic disease progression or present as part of the clinical manifestation, making diagnosis and treatment challenging. Our study reviewed the medical records of 31 patients who were candidates for postoperative treatment between June 2022 and June 2024.
View Article and Find Full Text PDFInt J Mol Sci
December 2023
Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Psoriasis is a chronic immune-mediated disease that is linked to an increased risk of cancer. Although numerous studies have explored whether neoplasms are concurrent conditions or are induced by psoriasis, a definitive definition remains elusive. In this study, we conducted a comprehensive narrative literature review to offer practical guidance to oncologists and dermatologists regarding the initiation and discontinuation of biologics for psoriasis.
View Article and Find Full Text PDFItal J Dermatol Venerol
February 2023
UOSD Dermatology, USL Toscana Centro-Prato Hospital, Prato, Italy.
Dermatol Reports
September 2022
UOSD Dermatology, USL Toscana Centro-Prato Hospital, Prato.
The use of multiple drugs acting as modulators of the immune system are common among patients with severe autoimmune diseases. In these clinical scenarios, great attention should be placed on diagnosing infective cutaneous disorders that can underly iatrogenic immunosuppression. Here within, we report a rare case of molluscum contagiosum eruption on the face and the scalp during an immunomodulating treatment for rheumatoid arthritis, with clinical and dermatoscopic characterization.
View Article and Find Full Text PDFDermatol Pract Concept
March 2021
Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, Policlinico Sant'Orsola-Malpighi, University of Bologna, Italy.
Dermatol Ther
November 2020
Unit of Dermatology, Department of Experimental Diagnostic and Specialty Medicine, Policlinico Sant' Orsola-Malpighi, University of Bologna, Bologna, Italy.
Clin Exp Dermatol
December 2020
PD Hinduja National Hospital and Sir HN Reliance Foundation Hospital, Mumbai, India.
Hidradenoma papilliferum (HP) is a rare, slow-growing, benign adnexal tumour with apocrine differentiation. It usually affects the anogenital region in adult women and is clinically polymorphous, mimicking other benign or malignant neoformations. The dermoscopic features of vulval HP have not been reported yet.
View Article and Find Full Text PDFClin Exp Dermatol
March 2020
Melanoma Division, IRCCS Istituto Europeo di Oncologia, Milan, Italy.
Background: Vulvar melanoma (VM) is rare and is often diagnosed late. Dermoscopy may aid in its recognition, differentiating VM from other more common vulvar lesions, such as melanosis and naevi. However, little is known about the dermoscopic features of thin VM.
View Article and Find Full Text PDFG Ital Dermatol Venereol
June 2017
Unit of Dermatology, USL Toscana Centro-Prato Hospital, Prato, Italy.
The last decades were characterized by a worldwide increasing incidence in melanoma. Almost 35% of diagnosed with melanoma women are in childbearing age. Malignant melanoma is the most common malignancy during pregnancy.
View Article and Find Full Text PDF